Skip Standard Navigation Links
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
peer-reviewed.gif (582 bytes)
eid_header.gif (2942 bytes)
Past Issue

Vol. 9, No. 3
March 2003

EID Home | Ahead of Print | Past Issues | EID Search | Contact Us | Announcements | Suggested Citation | Submit Manuscript

Comments | Email this article Email this article


Experimental Infection of North American Birds with the New York 1999 Strain of West Nile Virus

Nicholas Komar,* Stanley Langevin,* Steven Hinten,* Nicole Nemeth,*† Eric Edwards,*† Danielle Hettler,*† Brent Davis,* Richard Bowen,† and Michel Bunning*‡
*Centers for Disease Control and Prevention, Fort Collins, Colorado, USA; †Colorado State University, Fort Collins, Colorado, USA; and ‡Office of the Surgeon General, United States Air Force, Bolling Air Force Base, Washington, D.C., USA

Appendix A (online only)

Plaque-Reduction Neutralization Assay

Serum samples were assayed for West Nile virus (WNV)–specific antibodies by using the plaque-reduction neutralization test as previously described (1). Briefly, each serum sample was diluted 1:5 in BA1 and mixed with an equal volume of BA1 containing a suspension of WNV NY99-4132 at a concentration of approximately 200 PFU/0.1 mL, such that the final serum dilution was 1:10 and the final concentration of WNV was approximately 100 PFU/0.1 mL. For the postinoculation serum samples, we also tested serial twofold dilutions of serum to determine endpoint 90%-neutralization titers. In most cases, preinoculation serum samples were tested for neutralizing antibodies to St. Louis encephalitis virus, a closely related flavivirus that may cross-react serologically with WNV (2) and may partially protect against WNV infection (3). After 1 h incubation at 37°C, 5% CO2, virus-serum mixtures were assayed for virus content by plaque assay (see above). Controls used included BA1 only (cell viability control), bird serum-free virus mixture with BA1 only (to enumerate the number of PFU in the challenge dose of virus), and WNV hyperimmune mouse ascitic fluid (diluted 1:200) mixture with virus (positive control, to verify challenge virus identity).

Appendix A References

  1. Beaty BJ, Calisher CH, Shope RE. Arboviruses. In: Schmidt NJ, Emmons RW, editors. Diagnostic procedures for viral, rickettsial and chlamydial infections, 6th ed. Washington: American Public Health Association; 1989. p. 797–855.
  2. Calisher CH, Karabatsos N, Dalrymple JM, Shope RE, Porterfield JS, Westaway EG, et al. Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. J Gen Virol 1989;70:37–43.
  3. Tesh RB, Travassos da Rosa AP, Guzman H, Araujo TP, Xiao SY. Immunization with heterologous flaviviruses protective against fatal West Nile encephalitis. Emerg Infect Dis 2002;8:245–51.
   
     
   
Comments to the Authors

Please use the form below to submit correspondence to the authors or contact them at the following address:

Nicholas Komar, Centers for Disease Control and Prevention, P.O. Box 2087, Fort Collins, CO 80522, USA; fax: 970-221-6476; email: nck6@cdc.gov

Return email address optional:


 


Comments to the EID Editors
Please contact the EID Editors at eideditor@cdc.gov

Email this article

Your email:

Your friend's email:

Message (optional):

 

 

 

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page posted January 30, 2003
This page last reviewed January 5, 2004

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention